HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombotic Microangiopathies

Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
Also Known As:
Microangiopathies, Thrombotic; Microangiopathy, Thrombotic; Thrombotic Microangiopathy
Networked: 2595 relevant articles (83 outcomes, 108 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Atypical Hemolytic Uremic Syndrome
3. Pulmonary Hypertension
4. Thrombotic Thrombocytopenic Purpura
5. Infections

Experts

1. Jodele, Sonata: 37 articles (01/2022 - 08/2011)
2. Coppo, Paul: 35 articles (05/2022 - 10/2002)
3. Veyradier, Agnès: 30 articles (05/2022 - 04/2002)
4. Davies, Stella M: 26 articles (01/2022 - 08/2011)
5. Fakhouri, Fadi: 21 articles (09/2021 - 06/2005)
6. Frémeaux-Bacchi, Véronique: 20 articles (01/2022 - 11/2007)
7. Matsumoto, Masanori: 20 articles (01/2021 - 12/2003)
8. Dandoy, Christopher E: 18 articles (01/2022 - 01/2015)
9. Gavriilaki, Eleni: 16 articles (06/2022 - 06/2015)
10. Prohászka, Zoltán: 16 articles (06/2022 - 08/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Thrombotic Microangiopathies:
1. eculizumabFDA Link
2. Complement System Proteins (Complement)IBA
3. thiamine triphosphorate (TTP)IBA
4. CreatinineIBA
5. SteroidsIBA
6. Imatinib Mesylate (Gleevec)FDA Link
7. GemcitabineFDA Link
8. Heparin (Liquaemin)FDA LinkGeneric
9. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10. von Willebrand FactorIBA

Therapies and Procedures

1. Plasma Exchange
2. Therapeutics
3. Drug Therapy (Chemotherapy)
4. Aftercare (After-Treatment)
5. Transplantation